Back to search
FDAFDA · Food and drugs·Recall number D-0399-2026

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

Published March 11, 2026 · Recall initiated: February 24, 2026

Summary

FDA records drug Class II recall D-0399-2026, published March 11, 2026 and initiated February 24, 2026. Recalling firm: MYLAN PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 34850 blister packs; Lot: Lot #: 3116110, 3116130, Exp. Date 07/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if AMNESTEEM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMNESTEEM
Manufacturer
MYLAN PHARMACEUTICALS INC
Distributor
Nationwide within the United States
Lot
Lot #: 3116110, 3116130, Exp. Date 07/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93. recalled?

Yes. FDA published recall D-0399-2026 on March 11, 2026. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMNESTEEM.